Showing results (291-300 of 334) with videos related to

Sort By:
Pageof 34
BMC Public Health|August 7, 2010
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular riskHueiming Liu, Anushka Patel, Alex Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD TrialChloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
Cephalalgia : an International Journal of Headache|June 23, 2023
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysisCheryl Carcel, Faraidoon Haghdoost, Joanne Shen, et al.
Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
Heart (British Cardiac Society)|August 8, 2023
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressureEmily R Atkins, Alexander Chye, Thomas Lung, et al.
BMJ Open|July 15, 2025
Heart failure with reduced ejection fraction polypill implementation strategy in Sri Lanka: design and protocol of a pilot type I hybrid randomised clinical trialAnubha Agarwal, Asita de Silva, Mansi Agarwal, et al.
Antiviral Therapy|July 30, 2019
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trialJose M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
AIDS Research and Human Retroviruses|January 29, 2013
Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK StudyKathleen E Squires, Linda-Gail Bekker, Joseph J Eron, et al.
Pageof 34